SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
哭泣的坤
Lv1
20 积分
2022-08-08 加入
最近求助
最近应助
互助留言
Surgical treatment improves overall survival of hepatocellular carcinoma with extrahepatic metastases after conversion therapy: a multicenter retrospective study
1天前
已完结
Comparison of hepatic arterial infusion chemotherapy with mFOLFOX vs. first-line systemic chemotherapy in patients with unresectable intrahepatic cholangiocarcinoma
7天前
已完结
Postoperative adjuvant tyrosine kinase inhibitors combined with anti-PD-1 antibodies improves surgical outcomes for hepatocellular carcinoma with high-risk recurrent factors
8天前
已完结
Adjuvant Lenvatinib Plus PD-1 Antibody for Hepatocellular Carcinoma with High Recurrence Risks After Hepatectomy: A Retrospective Landmark Analysis
8天前
已完结
Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma
8天前
已完结
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial
8天前
已完结
Cancer incidence and mortality in China, 2022
12天前
已完结
Systemic chemotherapy plus transarterial chemoembolization versus systemic chemotherapy alone for unresectable intrahepatic cholangiocarcinoma: a multicenter retrospective cohort study
12天前
已完结
Clinical outcomes of hepatic arterial infusion chemotherapy combined with tyrosine kinase inhibitors and anti‐PD‐1 immunotherapy for unresectable intrahepatic cholangiocarcinoma
14天前
已完结
Efficacy and Safety of Nivolumab Plus Ipilimumab in Patients With Advanced Hepatocellular Carcinoma Previously Treated With Sorafenib
1个月前
已完结
没有进行任何应助
感谢,点赞,速度真快
1天前
点赞,速度真快,帮大忙了
7天前
感谢,点赞,速度真快,帮大忙了
8天前
点赞,速度真快
8天前
感谢,点赞
8天前
感谢,点赞,速度真快
8天前
感谢,速度真快
12天前
感谢,点赞,速度真快
12天前
感谢,点赞,速度真快
14天前
感谢,点赞
1个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论